Hillgene, a global CDMO specializing in end-to-end viral vector and cell therapy manufacturing solutions, is committed to advancing next-generation therapies through high-quality, scalable platforms. ...
The U.S. Food and Drug Administration (FDA) has removed the Risk Evaluation and Mitigation Strategies (REMS) requirements for currently approved BCMA- and CD19-directed CAR-T therapies, the agency ann...
On June 26, Professor Raju Kucherlapati, a world-renowned expert in genetics and medicine and member of the U.S. National Academy of Medicine (NAM), visited UPMED Biotech with his delegation. The two ...
IGC 2024 (the 8th Immuno-Gene and Cell Therapy Conference) was grandly opened on September 6-7 at the Beijing International Convention Center. During the period from 9:00 a.m. to 12:35 p.m. on Septemb...
December 3rd, 2024 "Building Bridges" conference in the global life sciences sector was held at the J Hotel in Shanghai, organized by the Wallonia Export & Investment Agency Investment a...
The 2024 Biopharmaceutical and Synthetic Biology Expert Exchange Conference, along with the Annual Meeting of the Gene Technology Engineering Research Center of the Ministry of Education, was held in ...
In order to improve the efficiency of drug review and approval, the National Medical Products Administration has decided to implement electronic submission of drug registration application materials. ...
On November 29, the State Food and Drug Administration publicly solicited opinions on the "Regulations on the Supervision and Management of Drug Quality by Drug Marketing Authorization Holders&qu...
On November 10, the 24th Shanghai International Biotechnology and Pharmaceutical Symposium (BIO-FORUM) Series | China Biotechnology and Pharmaceutical Innovation Forum and the 2022 China Biomedical Sc...
On November 1, the 2022 Suzhou Wuzhong (22nd) Taihu Economic and Trade Cooperation Fair was held on the banks of the beautiful Taihu Lake. Academician Zhang Dan, foreign academician of the Russian Aca...
According to the ICH official website, ICH Guideline E19 has entered the Step 5 stage of full implementation by ICH members. Academician Zhang Dan, Vice Chairman of Spectrum Biopharma, participated in...
On October 31, 2022, in order to guide the drug MAH to standardize the production and quality management of cell therapy products, the National Bureau Verification Center issued the "Guidelines f...
86 198 5711 6962 
info@hillgene.com 
English
